Search research articles
Contact Us
Filters
Showing results (101-110 of 251) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2018
Standardized Definition of Progression-Free Survival in Diffuse Large B-Cell Lymphoma Is Urgently Needed
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Overestimated Value of Baseline Total Metabolic Tumor Volume at <sup>18</sup>F-Labeled Fluorodeoxyglucose Positron Emission Tomography in Follicular Lymphoma
Hugo J A Adams, Thomas C Kwee
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 2017
Reply: Interim PET in Hodgkin Lymphoma: Is It So Useless?
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2015
Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma
Hugo J A Adams, Thomas C Kwee
Annals of Hematology
|
March 3, 2016
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis
Hugo J A Adams, Thomas C Kwee
International Journal of Radiation Oncology, Biology, Physics
|
October 14, 2015
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Regard to Simontacchi et al
Hugo J A Adams, Thomas C Kwee
British Journal of Haematology
|
March 29, 2016
Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2019
Only a Small Proportion of Patients With Early-Stage Hodgkin Lymphoma May Potentially Benefit From Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment Escalation
Hugo J A Adams, Thomas C Kwee
British Journal of Haematology
|
September 17, 2019
Value of detecting bone marrow involvement in Hodgkin lymphoma
Hugo J A Adams, Thomas C Kwee
The Lancet. Haematology
|
February 5, 2017
Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma
Hugo J A Adams, Thomas C Kwee
Page
of 26
Search research articles
Search
Showing results (101-110 of 251) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2018
Standardized Definition of Progression-Free Survival in Diffuse Large B-Cell Lymphoma Is Urgently Needed
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Overestimated Value of Baseline Total Metabolic Tumor Volume at <sup>18</sup>F-Labeled Fluorodeoxyglucose Positron Emission Tomography in Follicular Lymphoma
Hugo J A Adams, Thomas C Kwee
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 2017
Reply: Interim PET in Hodgkin Lymphoma: Is It So Useless?
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2015
Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma
Hugo J A Adams, Thomas C Kwee
Annals of Hematology
|
March 3, 2016
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis
Hugo J A Adams, Thomas C Kwee
International Journal of Radiation Oncology, Biology, Physics
|
October 14, 2015
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. In Regard to Simontacchi et al
Hugo J A Adams, Thomas C Kwee
British Journal of Haematology
|
March 29, 2016
Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2019
Only a Small Proportion of Patients With Early-Stage Hodgkin Lymphoma May Potentially Benefit From Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment Escalation
Hugo J A Adams, Thomas C Kwee
British Journal of Haematology
|
September 17, 2019
Value of detecting bone marrow involvement in Hodgkin lymphoma
Hugo J A Adams, Thomas C Kwee
The Lancet. Haematology
|
February 5, 2017
Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma
Hugo J A Adams, Thomas C Kwee
Page
of 26